
Neuralink is set to begin a groundbreaking clinical trial in October 2025, offering hope to individuals with severe speech impairments. The FDA-cleared study will test Neuralink's brain implant, designed to translate thoughts directly into text. This technology could revolutionize communication for those affected by conditions like spinal injuries and ALS.
from Science News: Fresh Discoveries, Research & Breakthroughs https://ift.tt/1e6asI3
via
IFTTT
0 Comments